🔗 Share this article

A shadow market for unlicensed slimming medications is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where communities with numerous of members share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the British medical regulations.

Some content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Platform Response and Content Elimination

According to the social media company, the service has taken down violative content and prohibited related keywords and search suggestions. The company said it was dedicated to keeping the service secure and investing in enhancing compliance measures.

Digital Trading Activities

Research also found groups with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of members, filled with images of weight loss, positive testimonials and detailed instructions for mixing or injecting at home.

Within moments of joining one community, a seller posted WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.

Item Information and Pricing

Within these groups, messages display black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A representative for Telegram stated it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they cannot confirm. Even if the research behind this drug is valid, these online versions may not include what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her team has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a company experimental product not yet authorized … may expose patients to potentially significant health risks”.